Bartal et al., 1976 - Google Patents
Pituitary tumors manifesting with amenorrhea-galactorrheaBartal et al., 1976
- Document ID
- 9143168188419572870
- Author
- Bartal A
- Razon N
- Publication year
- Publication venue
- Harefuah
External Links
Snippet
PIP: The amenorrhea-galactorrhea syndrome which occurs at a time other than the post- partum period is most often seen in association with a tumor of the pituitary gland; the symptoms are caused by a hypersecretion of prolactin. Among a series of 19 patients in Tel …
- 208000007913 Pituitary Neoplasms 0 title abstract description 8
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, E.G. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F13/00—Bandages or dressings; Absorbent pads
- A61F13/15—Absorbent pads, e.g. sanitary towels, swabs or tampons for external or internal application to the body; Supporting or fastening means therefor; Tampon applicators
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M25/00—Catheters; Hollow probes
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP0142426A3 (en) | Ophthalmic formulation containing norfloxacin and related antibiotics | |
EP1099445A3 (en) | Treatment of neuromuscular disorders and conditions with different botulinum serotype | |
CA2013877A1 (en) | Pre-curved dual lumen catheter | |
IE870993L (en) | Nasal administration compositions. | |
TW224428B (en) | ||
GR3004150T3 (en) | Medicaments for the treatment or prevention of the withdrawal syndrome. | |
WO1999033475A8 (en) | Galactosylceramide, glucosylceramide, lactosylceramide, and specific catchers therefor for use in the prophylaxis or therapy of prediabetes, diabetes and/or associated complications | |
EP0306347A3 (en) | Diagnosis and treatment of double-stranded rna deficiency states | |
EP0300680A3 (en) | Doublestranded rna correction of abnormalities in circulating immune complexes and monocyte function | |
WO1995024650A3 (en) | Methods of diagnosing and treating preeclampsia | |
EP0235589A3 (en) | Use of quinolone and naphthyridine antibiotics for the manufacture of ophthalmic medicaments | |
HK74787A (en) | Anthracycline glycosides | |
Bartal et al. | Pituitary tumors manifesting with amenorrhea-galactorrhea | |
CA2045605A1 (en) | Treatment of leukocyte dysfunction with gm-csf | |
EP0304294A3 (en) | Taliscanin and other aristolactams for treating neurological disorders, parkinson's disease, alzheimer disease and impotence | |
EP0147185A3 (en) | Therapeutic use of cytidyl disphosphocholine to increase neuronal acetylcholine | |
CA2069870A1 (en) | Treatment of atopic disorders with gamma-interferon | |
JPS5795914A (en) | Antithrombin-like drug | |
JPS6426518A (en) | Remedy for hyperophthalmotony | |
FI851170A7 (en) | Spiro-indenes and spiro-1,2-dihydronaphthalenes for the treatment of diabetic complications. | |
JPS55113721A (en) | Immunity regulator | |
JPS5585526A (en) | Remedy for allergic disease | |
Mitra et al. | Menstrual disorder after medical termination of pregnancy | |
Forconi et al. | Effect of HR (O-(beta-hydroxyethyl)-rutosides) on the impaired venous function of young females taking oral contraceptives. A strain gauge plethysmographic and clinical open controlled study | |
EP0200527A3 (en) | Norfloxacin salt |